ReproNovo raises $65 million Series A financing to advance phase 2 clinical trials of novel therapies in reproductive medicine and women’s health

by Ysios Capital

ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced the successful closing of a $65 million Series A financing round. The...

Read more

Asabys invests in €77.7 million round of Augustine Therapeutics

by Asabys Partners

The oversubscribed financing was co-led by Novo Holdings and Jeito Capital, supported by existing investors Asabys Partners, who led an initial EUR 17.5 million closing in 2024, Eli Lilly and Company,...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

The SETT Commits €24.5 Million to Atty...

by Sociedad Española para la Transformación Tecnológica (SETT)

Atypics Photonics, a newly established company, was born out of the Si...

Photos Stream